Putting Alzheimer’s on early notice

Jul 16, 2010
Putting Alzheimer’s on early notice
In vivo imaging of amyloid-beta plaques and brain atrophy of a healthy elderly person (left) compared to an Alzheimer's disease patient (right). (CSIRO)

Australian scientists have presented key findings at an international Alzheimer's disease conference this week. Their major focus is on early detection and discovering why the disease progresses.

The International Conference on in Hawaii heard that scientists from the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) have identified advances in imaging and blood screening that will contribute to the earlier detection of Alzheimer’s.

About 250,000 Australians currently have Alzheimer’s disease, but numbers are anticipated to rise to 1.3 million in the next 40 years if there were not significant breakthroughs in prevention and treatment of the disease.

The national collaborative approach taken by AIBL scientists was initiated by CSIRO’s Preventative Health National Research Flagship on Alzheimer’s prevention research and has resulted in 22 research papers being accepted and presented at the conference.

The director of CSIRO’s Preventative Health Flagship, Professor Richard Head, said many of the major contributions presented at the conference were only made possible through the national collaboration of scientists from a wide range of disciplines across Australia.

"This collaboration has provided critical expertise and capability at a size necessary to enable us to understand early identification of the disease and the contributing factors to its progression," Professor Head said. 

"The advancement in our research would not have been as strong or as rapid were it not for the broad range of expertise brought together by this collaboration."

The level of recognition from the world’s leading forum on research confirms the success of the initiative, he said.

Professor Head said the AIBL research has combined advanced neuroimaging, cognitive performance studies, blood screening and lifestyle studies to start identifying early indicators of the disease.

"The imaging component alone has potentially brought forward the detection of Alzheimer's disease by 18 months," he said.

Explore further: Ebola ruled out in Bolivia case

add to favorites email to friend print save as pdf

Related Stories

Advance towards early Alzheimer's diagnosis

Jun 18, 2008

The leader of the team that made the discovery, Professor Christopher Rowe of the Austin Hospital in Melbourne, says early diagnosis and treatment presents medical practitioners with the best opportunity to delay the onset ...

Alzheimer's disease to quadruple worldwide by 2050

Jun 10, 2007

More than 26 million people worldwide were estimated to be living with Alzheimer’s disease in 2006, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers also concluded ...

Advance in bowel cancer test research

Jun 04, 2009

(PhysOrg.com) -- Australian researchers have developed gene expression biomarkers which can accurately discriminate pre-cancerous and cancerous colorectal growths from non-cancerous controls.

Study finds certain drugs cut Alzheimer's

Dec 06, 2006

U.S. scientists say they've identified anti-hypertensive agents that can prevent cognitive decline and amyloid neuropathology in Alzheimer patients.

Recommended for you

Photodynamic therapy vs. cryotherapy for actinic keratoses

11 minutes ago

Photodynamic therapy (PDT, which uses topical agents and light to kill tissue) appears to better clear actinic keratoses (AKs, a common skin lesion caused by sun damage) at three months after treatment than cryotherapy (which ...

US official warns Ebola outbreak will get worse

1 hour ago

A third top doctor has died from Ebola in Sierra Leone, a government official said Wednesday, as a leading American health official warned that the outbreak sweeping West Africa would get worse before it ...

UN releases $1.5mn to help DR Congo fight Ebola

3 hours ago

The United Nations on Wednesday allocated $1.5 million (1.1 million euros) to help the Democratic Republic of Congo fight Ebola, just days after the country confirmed its first cases this year.

'Junk' blood tests may offer life-saving information

5 hours ago

Some 30 percent of all positive hospital blood culture samples are discarded every day because they're "contaminated"—they reflect the presence of skin germs instead of specific disease-causing bacteria.

Drug represents first potential treatment for common anemia

6 hours ago

An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the treatment published online today in Blood, the Journal of the American Society o ...

User comments : 0